Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
SIRO's Cash to Debt is ranked higher than
97% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.42 vs. SIRO: No Debt )
Ranked among companies with meaningful Cash to Debt only.
SIRO' s 10-Year Cash to Debt Range
Min: 0.05   Max: No Debt
Current: No Debt

Equity to Asset 0.70
SIRO's Equity to Asset is ranked higher than
71% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. SIRO: 0.70 )
Ranked among companies with meaningful Equity to Asset only.
SIRO' s 10-Year Equity to Asset Range
Min: -0.11   Max: 0.88
Current: 0.7

-0.11
0.88
Interest Coverage No Debt
SIRO's Interest Coverage is ranked higher than
95% of the 103 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 56.06 vs. SIRO: No Debt )
Ranked among companies with meaningful Interest Coverage only.
SIRO' s 10-Year Interest Coverage Range
Min: 1.68   Max: 9999.99
Current: No Debt

1.68
9999.99
F-Score: 6
Z-Score: 8.53
M-Score: -2.81
WACC vs ROIC
10.35%
19.43%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 20.91
SIRO's Operating margin (%) is ranked higher than
88% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.85 vs. SIRO: 20.91 )
Ranked among companies with meaningful Operating margin (%) only.
SIRO' s 10-Year Operating margin (%) Range
Min: -66.23   Max: 35.85
Current: 20.91

-66.23
35.85
Net-margin (%) 15.46
SIRO's Net-margin (%) is ranked higher than
85% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.03 vs. SIRO: 15.46 )
Ranked among companies with meaningful Net-margin (%) only.
SIRO' s 10-Year Net-margin (%) Range
Min: -64.92   Max: 45.97
Current: 15.46

-64.92
45.97
ROE (%) 14.00
SIRO's ROE (%) is ranked higher than
74% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.27 vs. SIRO: 14.00 )
Ranked among companies with meaningful ROE (%) only.
SIRO' s 10-Year ROE (%) Range
Min: -290.68   Max: 227.81
Current: 14

-290.68
227.81
ROA (%) 9.78
SIRO's ROA (%) is ranked higher than
80% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.87 vs. SIRO: 9.78 )
Ranked among companies with meaningful ROA (%) only.
SIRO' s 10-Year ROA (%) Range
Min: -73.05   Max: 68.42
Current: 9.78

-73.05
68.42
ROC (Joel Greenblatt) (%) 79.69
SIRO's ROC (Joel Greenblatt) (%) is ranked higher than
92% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.74 vs. SIRO: 79.69 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
SIRO' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -449.7   Max: 275.82
Current: 79.69

-449.7
275.82
Revenue Growth (3Y)(%) 9.30
SIRO's Revenue Growth (3Y)(%) is ranked higher than
75% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. SIRO: 9.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
SIRO' s 10-Year Revenue Growth (3Y)(%) Range
Min: -23.4   Max: 71.9
Current: 9.3

-23.4
71.9
EBITDA Growth (3Y)(%) 9.00
SIRO's EBITDA Growth (3Y)(%) is ranked higher than
57% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. SIRO: 9.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
SIRO' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -30.1   Max: 84
Current: 9

-30.1
84
EPS Growth (3Y)(%) 13.70
SIRO's EPS Growth (3Y)(%) is ranked higher than
61% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.20 vs. SIRO: 13.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
SIRO' s 10-Year EPS Growth (3Y)(%) Range
Min: -8.9   Max: 59
Current: 13.7

-8.9
59
» SIRO's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

SIRO Guru Trades in Q2 2014

Jeremy Grantham 43,800 sh (New)
Chuck Royce 1,040 sh (New)
Bill Frels Sold Out
Ruane Cunniff 2,851,162 sh (-2.04%)
Ron Baron 81,200 sh (-10.08%)
Paul Tudor Jones 2,600 sh (-18.75%)
Columbia Wanger 1,218,000 sh (-24.32%)
» More
Q3 2014

SIRO Guru Trades in Q3 2014

John Burbank 48,670 sh (New)
Dodge & Cox 3,405 sh (New)
Chuck Royce 5,380 sh (+417.31%)
Jeremy Grantham 76,116 sh (+73.78%)
Paul Tudor Jones Sold Out
Ruane Cunniff 2,833,679 sh (-0.61%)
Ron Baron 74,903 sh (-7.75%)
Columbia Wanger 950,000 sh (-22.00%)
» More
Q4 2014

SIRO Guru Trades in Q4 2014

Joel Greenblatt 37,067 sh (New)
Dodge & Cox 3,405 sh (unchged)
Ruane Cunniff 2,827,172 sh (unchged)
John Burbank Sold Out
Ruane Cunniff 2,827,172 sh (-0.23%)
Ron Baron 67,403 sh (-10.01%)
Jeremy Grantham 67,400 sh (-11.45%)
Chuck Royce 3,480 sh (-35.32%)
Columbia Wanger 575,231 sh (-39.45%)
» More
Q1 2015

SIRO Guru Trades in Q1 2015

Ruane Cunniff 2,827,202 sh (unchged)
Ron Baron 67,403 sh (unchged)
Columbia Wanger 575,231 sh (unchged)
Joel Greenblatt Sold Out
Chuck Royce Sold Out
Dodge & Cox Sold Out
Jeremy Grantham 64,800 sh (-3.86%)
» More
» Details

Insider Trades

Latest Guru Trades with SIRO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 31.20
SIRO's P/E(ttm) is ranked lower than
63% of the 108 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. SIRO: 31.20 )
Ranked among companies with meaningful P/E(ttm) only.
SIRO' s 10-Year P/E(ttm) Range
Min: 9.38   Max: 766.86
Current: 31.2

9.38
766.86
Forward P/E 21.83
SIRO's Forward P/E is ranked lower than
58% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.28 vs. SIRO: 21.83 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 31.40
SIRO's PE(NRI) is ranked lower than
57% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.40 vs. SIRO: 31.40 )
Ranked among companies with meaningful PE(NRI) only.
SIRO' s 10-Year PE(NRI) Range
Min: 9.34   Max: 782.2
Current: 31.4

9.34
782.2
P/B 4.60
SIRO's P/B is ranked lower than
90% of the 164 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. SIRO: 4.60 )
Ranked among companies with meaningful P/B only.
SIRO' s 10-Year P/B Range
Min: 0.84   Max: 11.56
Current: 4.6

0.84
11.56
P/S 4.80
SIRO's P/S is ranked lower than
112% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.75 vs. SIRO: 4.80 )
Ranked among companies with meaningful P/S only.
SIRO' s 10-Year P/S Range
Min: 0.74   Max: 7.44
Current: 4.8

0.74
7.44
PFCF 29.70
SIRO's PFCF is ranked lower than
91% of the 81 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. SIRO: 29.70 )
Ranked among companies with meaningful PFCF only.
SIRO' s 10-Year PFCF Range
Min: 9.65   Max: 99.96
Current: 29.7

9.65
99.96
POCF 22.80
SIRO's POCF is ranked lower than
69% of the 108 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.50 vs. SIRO: 22.80 )
Ranked among companies with meaningful POCF only.
SIRO' s 10-Year POCF Range
Min: 5.89   Max: 115.33
Current: 22.8

5.89
115.33
EV-to-EBIT 21.28
SIRO's EV-to-EBIT is ranked higher than
52% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.40 vs. SIRO: 21.28 )
Ranked among companies with meaningful EV-to-EBIT only.
SIRO' s 10-Year EV-to-EBIT Range
Min: 9.1   Max: 92.6
Current: 21.28

9.1
92.6
PEG 2.88
SIRO's PEG is ranked higher than
51% of the 59 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.88 vs. SIRO: 2.88 )
Ranked among companies with meaningful PEG only.
SIRO' s 10-Year PEG Range
Min: 0.39   Max: 18.7
Current: 2.88

0.39
18.7
Shiller P/E 40.20
SIRO's Shiller P/E is ranked lower than
101% of the 81 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.32 vs. SIRO: 40.20 )
Ranked among companies with meaningful Shiller P/E only.
SIRO' s 10-Year Shiller P/E Range
Min: 12.06   Max: 337.5
Current: 40.2

12.06
337.5
Current Ratio 2.87
SIRO's Current Ratio is ranked higher than
62% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.55 vs. SIRO: 2.87 )
Ranked among companies with meaningful Current Ratio only.
SIRO' s 10-Year Current Ratio Range
Min: 0.75   Max: 8.27
Current: 2.87

0.75
8.27
Quick Ratio 2.38
SIRO's Quick Ratio is ranked higher than
67% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. SIRO: 2.38 )
Ranked among companies with meaningful Quick Ratio only.
SIRO' s 10-Year Quick Ratio Range
Min: 0.17   Max: 7.7
Current: 2.38

0.17
7.7
Days Inventory 92.02
SIRO's Days Inventory is ranked higher than
71% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 121.06 vs. SIRO: 92.02 )
Ranked among companies with meaningful Days Inventory only.
SIRO' s 10-Year Days Inventory Range
Min: 41.2   Max: 182.58
Current: 92.02

41.2
182.58
Days Sales Outstanding 43.42
SIRO's Days Sales Outstanding is ranked higher than
82% of the 156 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.58 vs. SIRO: 43.42 )
Ranked among companies with meaningful Days Sales Outstanding only.
SIRO' s 10-Year Days Sales Outstanding Range
Min: 16.78   Max: 96.57
Current: 43.42

16.78
96.57

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 105.00
SIRO's Price/Net Current Asset Value is ranked lower than
142% of the 69 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. SIRO: 105.00 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
SIRO' s 10-Year Price/Net Current Asset Value Range
Min: 3.84   Max: 3510
Current: 105

3.84
3510
Price/Tangible Book 12.70
SIRO's Price/Tangible Book is ranked lower than
120% of the 149 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.20 vs. SIRO: 12.70 )
Ranked among companies with meaningful Price/Tangible Book only.
SIRO' s 10-Year Price/Tangible Book Range
Min: 1   Max: 198.23
Current: 12.7

1
198.23
Price/DCF (Projected) 2.00
SIRO's Price/DCF (Projected) is ranked lower than
85% of the 92 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. SIRO: 2.00 )
Ranked among companies with meaningful Price/DCF (Projected) only.
SIRO' s 10-Year Price/DCF (Projected) Range
Min: 0.53   Max: 12.81
Current: 2

0.53
12.81
Price/Median PS Value 1.40
SIRO's Price/Median PS Value is ranked lower than
86% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.00 vs. SIRO: 1.40 )
Ranked among companies with meaningful Price/Median PS Value only.
SIRO' s 10-Year Price/Median PS Value Range
Min: 0.04   Max: 2.19
Current: 1.4

0.04
2.19
Price/Peter Lynch Fair Value 3.60
SIRO's Price/Peter Lynch Fair Value is ranked lower than
136% of the 42 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. SIRO: 3.60 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
SIRO' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.48   Max: 30.26
Current: 3.6

0.48
30.26
Price/Graham Number 4.20
SIRO's Price/Graham Number is ranked lower than
108% of the 88 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. SIRO: 4.20 )
Ranked among companies with meaningful Price/Graham Number only.
SIRO' s 10-Year Price/Graham Number Range
Min: 0.7   Max: 14.32
Current: 4.2

0.7
14.32
Earnings Yield (Greenblatt) 4.70
SIRO's Earnings Yield (Greenblatt) is ranked higher than
67% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. SIRO: 4.70 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
SIRO' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.1   Max: 10.9
Current: 4.7

1.1
10.9
Forward Rate of Return (Yacktman) 11.14
SIRO's Forward Rate of Return (Yacktman) is ranked higher than
53% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.90 vs. SIRO: 11.14 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) only.
SIRO' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 2   Max: 56
Current: 11.14

2
56

Analyst Estimate

Sep15 Sep16
EPS($) 4.02 4.47
EPS without NRI($) 4.02 4.47

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:RXT.Germany,
Sirona Dental Systems Inc was founded in 1997 and completed an initial public offering of its common stock on July 1, 1997. The Company is a manufacturer of high-quality, technologically-advanced dental equipment, and is engaged in developing, manufacturing and marketing innovative solutions for dentists around the world. The Company provides a range of technologically advanced products in each of its four product segments: Dental CAD/CAM Systems; Imaging Systems; Treatment Centers; and Instruments. The Company markets its products globally to dental practices, clinics and laboratories through an international network of distributors. The global dental market encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Recent technological advancements in the dental equipment industry include 3D radiography, digital radiography, CAD/CAM technology, intra oral cameras and periodontal instruments. The market it serves comprises the whole working environment of a dentist or dental technician, including the dentist's chair, lights, imaging systems and dental CAD/CAM systems, instruments, as well as practice furniture and other dental or lab-based systems. Dental CAD/CAM Systems address the worldwide market for dental restorations, which includes several types of restorations, such as inlays, onlays, veneers, crowns, bridges, copings and bridge frameworks made from ceramic, metal or composite blocks. The Company has developed a range of imaging systems for 2D and 3D, panoramic and intra-oral applications that allow the dentist to accommodate the patient in a more efficient manner. Treatment Centers comprise a range of products from basic dentist chairs to sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, as well as specialist centers used in preventative treatment and for training purposes. In July 2008, the Company launched its new TENEO Treatment Center, which combines technology with a timeless design that provides both patient and dentist with the ultimate in convenience and comfort. The Company offers a range of instruments, including handheld and power-operated handpieces for cavity preparation, endodontics, periodontology and prophylaxis. The instruments are supplemented by multi-function tips, supply and suction hoses, as well as care and hygiene systems for instrument preparation. Its product information is actively made available to business publications, dentists, journals, professional organizations and dental schools, and its website. Sirona distributes its products globally to dental practices, clinics and laboratories through an international network of more than 480 distributors. The Companys registered trademarks include, Sirona, CEREC, Orthophos, Heliodent, inLab, CDR, and Schick. It competes with different companies which include large international companies as well as smaller companies that compete regionally or
» More Articles for SIRO

Headlines

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BWEN, DDMG, ZHNE, ENZ, SIRO Nov 28 2011 
Weekly CEO Buys Highlight: KMI, VGR, SIRO, PNK, MASI Nov 27 2011 
Sirona Dental Systems Inc. Reports Operating Results (10-K) Nov 18 2010 
Sirona Dental Systems Inc. (siro) Dir. Exec. VP. COO US Op Jeffrey Slovin sells 250,000 Shares Feb 23 2010 
Sirona Dental Systems Inc. (siro) Dir. Exec. VP. COO US Op Jeffrey Slovin sells 250,000 Shares Dec 17 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-K) Dec 04 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-Q) Jul 31 2009 
Sirona Reports Fiscal 2009 Third Quarter and Year-to-Date Results Jul 31 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-Q) May 06 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-Q) Feb 05 2009 

More From Other Websites
Sirona and OnDemand 3D Enter Into A Settlement and License Agreement For Dental Surgical Drill... May 19 2015
Sirona and OnDemand 3D Enter Into A Settlement and License Agreement For Dental Surgical Drill... May 19 2015
SIRONA DENTAL SYSTEMS, INC. Financials May 15 2015
Sirona Q2 Earnings Meet, Revenues Lag; View Maintained - Analyst Blog May 13 2015
10-Q for Sirona Dental Systems, Inc. May 10 2015
Sirona Dental Systems Inc Earnings Call scheduled for 8:30 am ET today May 08 2015
Sirona Dental meets 2Q profit forecasts May 08 2015
Sirona Dental meets 2Q profit forecasts May 08 2015
Q2 2015 Sirona Dental Systems Inc Earnings Release - Before Market Open May 08 2015
Sirona Reports Fiscal 2015 Second Quarter Results May 08 2015
SIRONA DENTAL SYSTEMS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... May 08 2015
Sirona Reports Fiscal 2015 Second Quarter Results May 08 2015
How these NYC dentists used tech to save big money May 07 2015
Why Earnings Season Could Be Great for Sirona Dental (SIRO) - Tale of the Tape May 07 2015
Can Cardinal Health (CAH) Keep Its Earnings Streak Alive? - Analyst Blog Apr 28 2015
Sirona to Report Second Quarter Fiscal 2015 Results on May 8th Apr 24 2015
Sirona to Report Second Quarter Fiscal 2015 Results on May 8th Apr 24 2015
IDS 2015: Sirona sets new standards with seamless integration for digital... Mar 20 2015
CEREC Meets Invisalign®: Sirona Expands Its Orthodontic Product Line to Include Invisalign Digital... Mar 10 2015
CEREC Meets Invisalign®: Sirona Expands Its Orthodontic Product Line to Include Invisalign Digital... Mar 10 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK